The role of matrix metalloproteinase-2 in the remodeling of cell-seeded vascular constructs subjected to cyclic strain.
Tissue engineering offers the opportunity to develop vascular substitutes that mimic the responsive nature of native arteries. A good blood vessel substitute should be able to remodel its matrix in response to mechanical stimulation, as imposed by the hemodynamic environment. We have developed a novel method of studying the influence of mechanical strain on the remodeling of cell-seeded collagen gel blood vessel analogs. We assessed the remodeling capacity by examining the effect of mechanical conditioning upon the expression of enzymes which remodel the extracellular matrix, called matrix metalloproteinases (MMPs), and upon the mechanical properties of the constructs. We found that subjecting collagen constructs to a 10% cyclic radial distention, over a course of 4 days, resulted in an overall increase in the production of MMP-2. Cyclic mechanical strain also stimulated enzymatic activation of latent MMP-2. We found that cyclic strain also significantly increased the mechanical strength and material modulus, as indicated by an increase in circumferential tensile properties of the constructs. These observations suggested that MMP-2-dependent remodeling affects the material properties of vascular tissue analogs. To further investigate this possible connection we examined the effects of dynamic conditioning in the presence of two nonspecific inhibitors of MMP activity. Interestingly, we found that nonspecific inhibition of MMP ablated the benefits of mechanical conditioning upon mechanical properties. Our observations suggest that a better understanding of the complex relation between mechanical stimulation and construct remodeling is key for the proper design of tissue-engineered blood vessel substitutes.
Seliktar
D
D
Institute for Bioengineering & Bioscience, Georgia Institute of Technology, Atlanta, USA. seliktar@biomed.mat.ethz.ch
Nerem
R M
RM
Galis
Z S
ZS
D001158:Arteries / Q000166:cytology / Q000201:enzymology / Q000254:growth & development; D019149:Bioreactors; D001807:Blood Vessel Prosthesis; D002478:Cells, Cultured; D002675:Child, Preschool; D003094:Collagen / Q000502:physiology; D004789:Enzyme Activation; D005782:Gels; D006801:Humans; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D061965:Matrix Metalloproteinase Inhibitors; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000201:enzymology* / Q000254:growth & development*; D011480:Protease Inhibitors / Q000494:pharmacology; D013314:Stress, Mechanical; D013718:Tensile Strength; D023822:Tissue Engineering / Q000379:methods*; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000494:pharmacology
D005782:Gels; D061965:Matrix Metalloproteinase Inhibitors; D011480:Protease Inhibitors; D019716:Tissue Inhibitor of Metalloproteinase-2; D003094:Collagen; D020778:Matrix Metalloproteinase 2